Neurologic complications of chemotherapy agents

@article{Kannarkat2007NeurologicCO,
  title={Neurologic complications of chemotherapy agents},
  author={G. Kannarkat and Erin E. Lasher and D. Schiff},
  journal={Current Opinion in Neurology},
  year={2007},
  volume={20},
  pages={719–725}
}
  • G. Kannarkat, Erin E. Lasher, D. Schiff
  • Published 2007
  • Medicine
  • Current Opinion in Neurology
    • Purpose of reviewTo review neurologic complications of common and recently developed chemotherapeutic agents, as well as recent research regarding ‘chemobrain’. Recent findingsBortezomib, a new anticancer agent, has a propensity toward causing a largely sensory and reversible peripheral neuropathy. Infusion of magnesium and calcium pre and post-oxaliplatin infusion reduces neuropathy but may interfere with clinical response to oxaliplatin. No other measures currently reduce the incidence or… CONTINUE READING
    View on Wolters Kluwer
    ncbi.nlm.nih.gov
    165 Citations
    Highly Influencial Citations
    5
    Background Citations
    65
    Results Citations
    2
    165 Citations
    Citation Type

    Citation Type

    Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.
    • 84
    • Highly Influenced
    Neurotoxicity of chemotherapy
    • 3
    [Chemotherapy-induced peripheral neuropathy: an unresolved issue].
    • 59
    Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
    • 494
    • PDF
    Animal models of chemotherapy-evoked painful peripheral neuropathies
    • 98
    • PDF
    Nutraceuticals for Prevention of Chemotherapy-Induced Peripheral Neuropathy
    • 1
    • PDF
    Neurochemical characterization of primary sensory neurons in a rat model of bortezomic-induced peripheral neuropathy
    Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology
    • 1
    Complications neurologiques des traitements des tumeurs cérébrales
    • 14
    An Overview of Chemotherapy-Induced Peripheral Neuropathy
    • 2

    References

    SHOWING 1-10 OF 52 REFERENCES
    Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.
    • 192
    Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study
    • 79
    [Reduction of oxaliplatin-related neurotoxicity by calcium and magnesium infusions].
    • 13
    Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions
    • 329
    • PDF
    CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo
    • 401
    A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels.
    • 290
    • PDF
    Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.
    • 549
    • PDF
    Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat
    • 216
    Candidate mechanisms for chemotherapy-induced cognitive changes
    • 659
    Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity.
    • 80